Physician profile
David G Holmes
NPI 1467489286
$12,446.85
in general payments reported to CMS, 2019-2025
46 companies · $1,740 in 2025
The $1,740 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,785 · 2020: $1,903 · 2021: $1,686 · 2022: $1,198 · 2023: $2,263 · 2024: $1,873 · 2025: $1,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,857 · Education: $18.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,857.07 |
| Education | $18.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,994.37 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Latitude Communicator Power Supply, Essentio Sr |
| Actelion Pharmaceuticals US, INC. | $1,128.62 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $1,023.65 | 2019-2025 | Repatha, Repatha |
| Elutia, INC. | $786.39 | 2019-2023 | |
| Amarin Pharma, INC. | $707.06 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $575.24 | 2020-2025 | Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $552.75 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $477.59 | 2019-2024 | Xarelto |
| Medtronic, INC. | $450.46 | 2021-2025 | Symplicity G3, Onyx Frontier, Micra |
| United Therapeutics Corporation | $410.83 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Novartis Pharmaceuticals Corporation | $366.66 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $292.72 | 2022-2025 | Verquvo, Capvaxive |
| Inari Medical, INC. | $260.93 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $256.99 | 2019-2025 | |
| Esperion Therapeutics, INC. | $231.73 | 2020-2025 | Nexletol |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $226.96 | 2019-2021 | |
| Inspire Medical Systems, INC. | $222.39 | 2024-2025 | Inspire |
| Cvrx, INC. | $195.21 | 2021 | |
| Cagent Vascular INC | $194.86 | 2025 | Serrantor |
| E.R. Squibb & Sons, L.L.C. | $192.86 | 2022-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $183.08 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $168.96 | 2019-2025 | |
| Shockwave Medical, INC | $151.78 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $148.06 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Hitachi Healthcare Americas Corp. | $141.38 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $132.93 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $128.66 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.47 | 2021-2024 | Jardiance |
| Braemar Manufacturing, LLC | $98.86 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $92.15 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $80.13 | 2019-2022 | |
| Cardiva Medical, INC. | $69.85 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Edwards Lifesciences Corporation | $65.52 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Regeneron Healthcare Solutions, INC. | $55.42 | 2019 | |
| Gilead Sciences, INC. | $53.51 | 2019 | |
| Biosense Webster, INC. | $40.79 | 2022-2023 | Carto 3 |
| Atricure, INC. | $28.95 | 2023 | |
| Heartflow, INC. | $24.36 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $22.41 | 2019-2020 | |
| Medtronic Vascular, INC. | $21.26 | 2020 | |
| Recor Medical INC | $19.40 | 2025 | Paradise Ultrasound Renal Denervation System |
| Terumo Medical Corporation | $16.67 | 2024 | Angio-Seal |
| Irhythm Technologies, INC. | $15.27 | 2020 | |
| Alnylam Pharmaceuticals INC. | $14.92 | 2021 | |
| Siemens Medical Solutions USA, INC. | $12.43 | 2020 | |
| Celonova Biosciences, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.